Active Ingredient: APOMORPHINE HYDROCHLORIDE
Proprietary Name: APOKYN
Dosage Form; Route of Administration: INJECTABLE; SUBCUTANEOUS
Strength: 30MG/3ML (10MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N021264
Product Number: 002
Approval Date: Apr 20, 2004
Applicant Holder Full Name: MDD US OPERATIONS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information